Renaissance Capital logo

Outset Medical Priced, Nasdaq: OM

Provides a hemodialysis system for kidney diseases.

Industry: Health Care

Latest Trade: $15.62 +0.76 (+5.1%)

First Day Return: +124.7%

Return from IPO: -45.0%

Industry: Health Care

Outset is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. We believe the Tablo Hemodialysis System (Tablo) represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. We designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. Our technology is designed to elevate the dialysis experience for patients, and help providers overcome traditional care delivery challenges. Requiring only an electrical outlet and tap water to operate, Tablo frees patients and providers from the burdensome infrastructure required to operate traditional dialysis machines. We believe Tablo empowers patients, who have traditionally been passive recipients of care, to regain agency and ownership of their treatment. Tablo is currently cleared by the United States Food and Drug Administration (FDA) for use in the hospital, clinic or home setting.
more less
IPO News for Outset Medical
more
IPO Data
IPO File Date 08/21/2020
Offer Price $27.00
Price Range $22.00 - $24.00
Offer Shares (mm) 9.0
Deal Size ($mm) $242
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 09/14/2020
Offer Price $27.00
Price Range $22.00 - $24.00
Offer Shares (mm) 9.0
Deal Size ($mm) $242
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters San Jose, CA
Founded 2003
Employees 273
Website www.outsetmedical.com